Advertisement
Screener

Beyond Air, Inc. (XAIR) Provision for Other Losses

2.3 / 5 stars · 23/49 Roast Me

Beyond Air, Inc. Provision for Other Losses

Beyond Air, Inc. (XAIR) reported Provision for Other Losses of $91.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ProvisionForOtherLosses · last filed 2026-08-13

  • Beyond Air, Inc. provision for other losses for the quarter ending 2026-06-30 was $91.00K, a 12.50% decline year-over-year.
  • Beyond Air, Inc. provision for other losses for the quarter ending 2026-03-31 was -$395.00K.
  • Beyond Air, Inc. provision for other losses for the quarter ending 2025-12-31 was $247.00K, a 2987.50% increase year-over-year.
  • Beyond Air, Inc. provision for other losses for the quarter ending 2025-09-30 was $135.00K.
  • Beyond Air, Inc. provision for other losses for fiscal 2026 was $91.00K, a 48.59% decline from fiscal 2025.
  • Beyond Air, Inc. provision for other losses for fiscal 2025 was $177.00K.
  • Beyond Air, Inc. provision for other losses for fiscal 2023 was $49.00K.
Period endProvision for Other Losses 3 monthProvision for Other Losses 6 monthProvision for Other Losses 9 monthProvision for Other Losses 12 month
2026-06-30$91.00K
10-Q · filed 2026-08-13
-$304.00K
derived: sum of 2 quarters · filed 2026-08-13
-$57.00K
derived: sum of 3 quarters · filed 2026-08-13
$78.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$395.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26
-$148.00K
derived: sum of 2 quarters · filed 2026-06-26
-$13.00K
derived: sum of 3 quarters · filed 2026-06-26
$91.00K
10-K · filed 2026-06-26
2025-12-31$247.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13
$382.00K
derived: sum of 2 quarters · filed 2026-02-13
$486.00K
10-Q · filed 2026-02-13
$322.00K
derived: sum of 4 quarters · filed 2026-02-13
2025-09-30$135.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-10
$239.00K
10-Q · filed 2025-11-10
$75.00K
derived: sum of 3 quarters · filed 2025-11-10
$83.00K
derived: sum of 4 quarters · filed 2026-02-13
2025-06-30$104.00K
10-Q · filed 2025-08-12
-$60.00K
derived: sum of 2 quarters · filed 2025-08-12
-$52.00K
derived: sum of 3 quarters · filed 2026-02-13
2025-03-31-$164.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20
-$156.00K
derived: sum of 2 quarters · filed 2026-02-13
$177.00K
10-K · filed 2025-06-20
2024-12-31$8.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-13
$341.00K
10-Q · filed 2026-02-13
2024-09-30$333.00K
10-Q · filed 2025-11-10
2023-09-30$61.00K
10-Q · filed 2023-11-13
2023-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24
$0.00
derived: sum of 2 quarters · filed 2024-06-24
$49.00K
10-K · filed 2024-06-24
2022-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-12
$49.00K
10-Q · filed 2024-02-12
2022-09-30$49.00K
10-Q · filed 2023-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Tenon Medical, Inc. (TNON)United States$0.002B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Profusa, Inc. (PFSA)United States$0.002B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B